Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Pass Above 50 Day Moving Average of $1.77 etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Insider Buying: Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Insider Buys $34,600.00 in Stock dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the stock. Other equities research analysts have also issued reports about the stock. Cantor Fitzgerald upped their price target on shares of Corvus Pharmaceuticals from $2.00 to $4.00 in […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Short Interest Down 17.7% in July theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report)’s share price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.56 and traded as low as $2.04. Corvus Pharmaceuticals shares last traded at $2.24, with a volume of 113,815 shares changing hands. Analyst Upgrades […]